Netscientific Investors - NSCI

Netscientific Investors - NSCI

Buy
Sell
Best deals to access real time data!
Silver
Monthly Subscription
for only
£17.37
Level 2 Basic
Monthly Subscription
for only
£62.08
UK/US Silver
Monthly Subscription
for only
£30.59
VAT not included
Stock Name Stock Symbol Market Stock Type Stock ISIN Stock Description
Netscientific Plc NSCI London Ordinary Share GB00BN4R5Q82 ORD 5P
  Price Change Price Change % Stock Price Last Trade
0.00 0.0% 63.50 08:00:17
Open Price Low Price High Price Close Price Previous Close
64.50 61.10 64.50 63.50 63.50
more quote information »
Industry Sector
HEALTH CARE EQUIPMENT & SERVICES

Top Investor Posts

DateSubject
31/3/2021
15:14
horndean eagle: They do a terrible job in promoting the company. the PDSB stake is worth a lot more than end Dec value and yet they didn't even bother flagging it up. Haven't really even introduced investors to the portfolio companies yet either. Why they needed to wait a few weeks before investor meet is beyond me.
30/3/2021
07:49
the stigologist: Interesting that they are planning a Investor Presentation
22/3/2021
11:16
albert arthur: https://www.share-talk.com/zaks-sunday-roast-weapons-grade-analysis-of-stocks-and-the-markets-by-traders-and-investors/#gs.wa1475
17/3/2021
19:21
the stigologist: PDSB strong some very interesting slides being presented at Investor Conferences especially re expediting pipeline into commercial sales
23/2/2021
19:28
the stigologist: NSCI One of few stocks up today In a 'bio/med tech 'bull market' it's around the same price as during Covid crash around March last year But it has some decent investments Glycotest - Liver cancer diagnostic with Fosun owning c.40% and advancing it in China PDS Biotech - Cancer immunotherapy + Covid/Flu vaccine play ProAxsis - no idea but it's received about £1m in Government funding so must have something commercialisable ?! NSCI top 2 investors own 60% of the stock Glycotest I believe could be the jewel in the crown with Market Opportunity of $1bn+ p.a. NSCI at £9m Mkt Cap seems too cheap as a 60% play on Glycotest alone Golden Cross incoming...
22/2/2021
13:43
the stigologist: Vaccine news from PDSB htTps://pdsbiotech.com/investors/news-center/press-releases/press-releases1/113-2021-news/485-iotechandarmacorennouncelanvertooinonsorti20210222
11/2/2021
12:37
the stigologist: Why did Glycotest put together an Investor Presentation in November 2020 ? Was it to deliver to existing investors who already know the story and are on the Board ? (Fosun and NetScientific) - Doubt it. Was it to new potential investors ? - Probably Was it to potential SPAC buyers ? - Possibly
10/2/2021
13:41
loafofbread: 1.9M trades so far. Pretty good considering there's only 15M in total. Investors might start looking at the rest of the portfolio before to long?
02/2/2021
13:42
samsung2020: All normal investors apart from StiggleworthlessStiggy who is clearly is busy bumming his mum hence can't be polite,Anyway, Just spoken to link who knows folks at NSCI, they reckon this suspension will be a few days, at best and was totally unexpected. Be interesting to see how this works
02/2/2021
06:23
the stigologist: Management here seem more focused on feathering their own nest rather than be straight with investors
ADVFN Advertorial
Your Recent History
LSE
NSCI
Netscienti..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210416 00:42:48